ArticleCureus2025

Late-Onset Immune-Mediated Hepatotoxicity Induced by the Immune Checkpoint Inhibitor Pembrolizumab in Lung Cancer: A Case Report.

Jacobo Echeverri-Hoyos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.